Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1 b KEYNOTE-028 study.

被引：26
|
作者：
Mehnert, Janice M.
Varga, Andrea
Brose, Marcia
Aggarwal, Rahul Raj
Lin, Chia-Chi
Prawira, Amy
de Braud, Filippo
Tamura, Kenji
Doi, Toshihiko
Piha-Paul, Sarina Anne
Gilbert, Jill
Saraf, Sanatan
Thanigaimani, Pradeep
Cheng, Jonathan D.
Keam, Bhumsuk
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] Gustave Roussy, Villejuif, France
[3] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
[6] Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[8] Natl Canc Ctr Hosp Tokyo, Tokyo, Japan
[9] Natl Canc Ctr Hosp East, Chiba, Japan
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[12] Merck & Co Inc, Kenilworth, NJ USA
[13] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6091
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
    Chung, Hyun Cheol
    Piha-Paul, Sarina A.
    Lopez-Martin, Jose
    Schellens, Jan H. M.
    Kao, Steven
    Miller, Wilson H., Jr.
    Delord, Jean-Pierre
    Gao, Bo
    Planchard, David
    Gottfried, Maya
    Zer, Alona
    Jalal, Shadia I.
    Penel, Nicolas
    Mehnert, Janice M.
    Matos, Ignacio
    Bennouna, Jaafar
    Kim, Dong-Wan
    Xu, Lei
    Krishnan, Suba
    Norwood, Kevin
    Ott, Patrick A.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : 618 - 627
  • [32] Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
    Hsu, Chiun
    Lee, Se-Hoon
    Ejadi, Samuel
    Even, Caroline
    Cohen, Roger B.
    Le Tourneau, Christophe
    Mehnert, Janice M.
    Algazi, Alain
    van Brummelen, Emilie M. J.
    Saraf, Sanatan
    Thanigaimani, Pradeep
    Cheng, Jonathan D.
    Hansen, Aaron R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 4050 - +
  • [33] Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028
    Ott, P. A.
    Piha-Paul, S. A.
    Munster, P.
    Pishvaian, M. J.
    Van Brummelen, E.
    Cohen, R.
    Gomez-Roca, C.
    Ejadi, S.
    Stein, M.
    Chan, E.
    Simonelli, M.
    Morosky, A.
    Yuan, S. S.
    Koshiji, M.
    Bennouna, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S102 - S102
  • [34] Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study
    Schellens, Jan H. M.
    Marabelle, Aurelien
    Zeigenfuss, Susan
    Ding, Jie
    Pruitt, Scott Knowles
    Chung, Hyun Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Pembrolizumab for Advanced Mesothelioma: Results from the Phase 2 KEYNOTE-158 Study
    Yap, T. A.
    Nakagawa, K.
    Fujimoto, N.
    Kuribayashi, K.
    Guren, T.
    Calabro, L.
    Frommer, R. S.
    Gao, B.
    Kao, S.
    Matos, I.
    Planchard, D.
    Chatterjee, A.
    Jin, F.
    Norwood, K.
    Kindler, H. L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S3 - S4
  • [36] RESULTS OF THE PHASE IB KEYNOTE-028 MULTI-COHORT TRIAL OF PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT PD-L1-POSITIVE GLIOBLASTOMA MULTIFORME (GBM)
    Reardon, David A.
    Kim, Tae-Min
    Frenel, Jean-Sebastien
    Santoro, Armando
    Lopez, Juanita
    Subramaniam, Deepa S.
    Siu, Lillian L.
    Rodon, Jordi
    Tamura, Kenji
    Saraf, Sanatan
    Morosky, Anne
    Stein, Karen
    Soria, Jean-Charles
    NEURO-ONCOLOGY, 2016, 18 : 25 - 26
  • [37] Pembrolizumab treatment of advanced cervical cancer: updated results from the phase II KEYNOTE-158 study
    Chung, Hyun
    Delord, Jean-Pierre
    Perets, Ruth
    Italiano, Antoine
    Shapira-Frommer, Ronnie
    Manzuk, Lyudmila
    Piha-Paul, Sarina
    Xu, Lei
    Jin, Fan
    Norwood, Kevin
    Leary, Alexandra
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S27 - S27
  • [38] Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE-158 study
    Chung, Hyun Cheol
    Schellens, Jan H. M.
    Delord, Jean-Pierre
    Perets, Ruth
    Italiano, Antoine
    Shapira-Frommer, Ronnie
    Manzuk, Lyudmila
    Piha-Paul, Sarina Anne
    Wang, Jiangdian
    Zeigenfuss, Susan
    Pruitt, Scott K.
    Marabelle, Aurelien
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study
    Yokota, K.
    Takenouchi, T.
    Fujimoto, M.
    Ihn, H.
    Uchi, H.
    Inozume, T.
    Kiyohara, Y.
    Uhara, H.
    Nakagawa, K.
    Furukawa, H.
    Wada, H.
    Noguchi, K.
    Shimamoto, T.
    Yamazaki, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S672 - S672
  • [40] Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
    Oh, Do-Youn
    Algazi, Alain
    Capdevila, Jaume
    Longo, Federico
    Miller, Jr Wilson
    Bing, Jerry Tan Chun
    Eduardo Bonilla, Carlos
    Chung, Hyun Cheol
    Guren, Tormod K.
    Lin, Chia-Chi
    Motola-Kuba, Daniel
    Shah, Manisha
    Hadoux, Julien
    Yao, Lili
    Jin, Fan
    Norwood, Kevin
    Lebellec, Loic
    CANCER, 2023, 129 (08) : 1195 - 1204
12345